browse Browse

pac.dog pac.dog / Bills

HB 838State Board of Pharmacy - Prescriber-Pharmacist Agreements

MD 2026RS session · introduced 2026-02-04

Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

Latest action: Approved by the Governor - Chapter 53

Sponsors (17)
Action timeline (9)
  1. · house First Reading
  2. · house Hearing — Health
  3. · house Second Reading — Passed with Amendments
  4. · senate First Reading (cross-filed)
  5. · house Third Reading — Passed
  6. · house Committee Report — Favorable with Amendments
  7. · senate Second Reading — Passed
  8. · senate Third Reading — Passed
  9. · senate Committee Report — Favorable
Text versions (0)

No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.

Bill text (extracted)
Amendments
Congressional Research Service briefs (0)

CRS reports that cite this bill in their relatedMaterials — what Congress was reading on the topic. Click any report for its summary, formats, and bill-citation walk.

No CRS reports cite this bill yet.

Connected on the graph

2 typed relationships in the influence graph — 0 inbound, 2 outbound, grouped by type.

referred to committee (2)
datedirentityamountrolesource
Senate financemd-leg
House healthmd-leg
Who matters on this bill

Who matters

Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.

#MemberRoleSpeechesVotedScore
1Bonnie Cullison (D, state_lower MD-19)sponsor05
2Aaron M. Kaufman (D, state_lower MD-18)cosponsor01
3Ashanti Martinez (D, state_lower MD-22)cosponsor01
4Deni Taveras (D, state_lower MD-47)cosponsor01
5Heather Bagnall (D, state_lower MD-33)cosponsor01
6Jennifer White Holland (D, state_lower MD-10)cosponsor01
7Kathy Szeliga (R, state_lower MD-7)cosponsor01
8Kim Ross (D, state_lower MD-8)cosponsor01
9Lesley J. Lopez (D, state_lower MD-39)cosponsor01
10Nicholaus R. Kipke (R, state_lower MD-31)cosponsor01
11Pam Lanman Guzzone (D, state_lower MD-13)cosponsor01
12Samuel I. Rosenberg (D, state_lower MD-41)cosponsor01
13Teresa E. Reilly (R, state_lower MD-35)cosponsor01
14Teresa Woorman (D, state_lower MD-16)cosponsor01
15Terri L. Hill (D, state_lower MD-12)cosponsor01
16Thomas S. Hutchinson (R, state_lower MD-37)cosponsor01
17Tiffany T. Alston (D, state_lower MD-24)cosponsor01
Stance (positions taken)

Predicted vote

Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.

0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)

By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no

Timeline

Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; the inline strip under the row shows the counterpart's own context (a bill's latest action, a hearing's chamber + date, a filing's form type + filed date, a clip's source + excerpt) so the timeline reads like a Wikipedia citation rail.

  1. 2026-05-24 · was referred to Senate finance · md-leg
  2. 2026-05-24 · was referred to House health · md-leg
News clips about this bill
Mentioned in /ask threads

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.